Cited by 24Inflammasome and immune disordersImmune Response and InflammationSirtuins and Resveratrol in Medicine

Intracellular NAD+ Depletion Confers a Priming Signal for NLRP3 Inflammasome Activation

Open access
Shim, Do-Wan, Cho, Hyo-Joung, Hwang, Inhwa, Jung, Taek-Yeol, Kim, Hyun-Seok, Ryu, Ju Hee, Yu, Je-Wook·2021·Frontiers in Immunology

Abstract

Nicotinamide adenine dinucleotide (NAD+) is an important cofactor in many redox and non-redox NAD+-consuming enzyme reactions. Intracellular NAD+ level steadily declines with age, but its role in the innate immune potential of myeloid cells remains elusive. In this study, we explored whether NAD+ depletion by FK866, a highly specific inhibitor of the NAD salvage pathway, can affect pattern recognition receptor-mediated responses in macrophages. NAD+-depleted mouse bone marrow-derived macrophages (BMDMs) exhibited similar levels of proinflammatory cytokine production in response to LPS or poly (I:C) stimulation compared with untreated cells. Instead, FK866 facilitated robust caspase-1 activation in BMDMs in the presence of NLRP3-activating signals such as ATP and nigericin, a potassium ionophore. However, this FK866-mediated caspase-1 activation was completely abolished in Nlrp3-deficient macrophages. FK866 plus nigericin stimulation caused an NLRP3-dependent assembly of inflammasome complex. In contrast, restoration of NAD+ level by supplementation with nicotinamide mononucleotide abrogated the FK866-mediated caspase-1 cleavage. FK866 did not induce or increase the expression levels of NLRP3 and interleukin (IL)-1β but drove mitochondrial retrograde transport into the perinuclear region. FK866-nigericin-induced mitochondrial transport is critical for caspase-1 cleavage in macrophages. Consistent with the in vitro experiments, intradermal coinjection of FK866 and ATP resulted in robust IL-1β expression and caspase-1 activation in the skin of wild-type, but not Nlrp3-deficient mice. Collectively, our data suggest that NAD+ depletion provides a non-transcriptional priming signal for NLRP3 activation via mitochondrial perinuclear clustering, and aging-associated NAD+ decline can trigger NLRP3 inflammasome activation in ATP-rich environments.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2021.765477

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • NLRP3 inflammasome activation increases glycolytic metabolites such as fructose 1,6-biphosphate via PFK-1 and reduces NAD, with no change in cystine or betaine.

    “NLRP3 inflammasome activation also increased glycolytic metabolites45 such as fructose 1, 6-biphosphate via phosphofructokinase-1,46 alongside reduced nicotinamide adenine dinucleotide (NAD) (Figure 2A), a key cofactor in redox reactions,47 with no change in cystine (the oxidized dimeric form of cysteine) or betaine, an organic osmolyte in the methionine cycle (Figures 2B and Figure S2C).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 26

  1. [1]Neves J Sousa-Victor P. Regulation of Inflammation as an Anti-Aging Intervention. FEBS J (2020) 287(1): 43– 52. doi: 10.1111/febs.15061 31529582 · DOI
  2. [3]Franceschi C Campisi J. Chronic Inflammation (Inflammaging) and its Potential Contribution to Age-Associated Diseases. J Gerontol Ser A: Biomed Sci Med Sci (2014) 69(Suppl_1): S4–9. doi: 10.1093/gerona/glu057 24833586 · DOI · Paper page
  3. [4]Tsai C-Y Shen C-Y Liao H-T Li K-J Lee H-T Lu C-S. Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking “Inflammaging” in Patients With Systemic Lupus Erythematosus. Int J Mol Sci (2019) 20(16): 3878. doi: 10.3390/ijms20163878 PMC6721773 31395799 · DOI
  4. [5]Calabrese V Santoro A Monti D Crupi R Di Paola R Latteri S. Aging and Parkinson’s Disease: Inflammaging, Neuroinflammation and Biological Remodeling as Key Factors in Pathogenesis. Free Radical Biol Med (2018) 115: 80– 91. doi: 10.1016/j.freeradbiomed.2017.10.379 29080843 · DOI · Paper page
  5. [7]McReynolds MR Chellappa K Baur JA. Age-Related NAD+ Decline. Exp Gerontol (2020) 134: 110888. doi: 10.1016/j.exger.2020.110888 32097708 PMC7442590 · DOI
  6. [8]Xiao W Wang RS Handy DE Loscalzo J. NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism. Antioxid Redox Signal (2018) 28(3): 251–72. doi: 10.1089/ars.2017.7216 PMC5737637 28648096 · DOI
  7. [10]Li X-Q Lei J Mao L-H Wang Q-L Xu F Ran T. NAMPT and NAPRT, Key Enzymes in NAD Salvage Synthesis Pathway, Are of Negative Prognostic Value in Colorectal Cancer. Front Oncol (2019) 9: 736. doi: 10.3389/fonc.2019.00736 31448236 PMC6691178 · DOI
  8. [13]Yoshino J Mills KF Yoon MJ Imai S-i. Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet-and Age-Induced Diabetes in Mice. Cell Metab (2011) 14(4): 528–36. doi: 10.1016/j.cmet.2011.08.014 PMC3204926 21982712 · DOI · Paper page
  9. [14]Katsyuba E Romani M Hofer D Auwerx J. NAD(+) Homeostasis in Health and Disease. Nat Metab (2020) 2(1): 9– 31. doi: 10.1038/s42255-019-0161-5 32694684 · DOI · Paper page
  10. [15]Yang K Lauritzen KH Olsen MB Dahl TB Ranheim T Ahmed MS. Low Cellular NAD+ Compromises Lipopolysaccharide-Induced Inflammatory Responses via Inhibiting TLR4 Signal Transduction in Human Monocytes. J Immunol (2019) 203(6): 1598–608. doi: 10.4049/jimmunol.1801382 31427442 · DOI
  11. [16]Cameron AM Castoldi A Sanin DE Flachsmann LJ Field CS Puleston DJ. Inflammatory Macrophage Dependence on NAD+ Salvage is a Consequence of Reactive Oxygen Species–Mediated DNA Damage. Nat Immunol (2019) 20(4): 420–32. doi: 10.1038/s41590-019-0336-y PMC12842115 30858618 · DOI · Paper page
  12. [17]Gim E Shim DW Hwang I Shin OS Yu JW. Zika Virus Impairs Host NLRP3-Mediated Inflammasome Activation in an NS3-Dependent Manner. Immune Netw (2019) 19(6): e40. doi: 10.4110/in.2019.19.e40 31921470 PMC6943171 · DOI
  13. [18]Fernandes-Alnemri T Yu JW Datta P Wu J Alnemri ES. AIM2 Activates the Inflammasome and Cell Death in Response to Cytoplasmic DNA. Nature (2009) 458(7237): 509–13. doi: 10.1038/nature07710 PMC2862225 19158676 · DOI · Paper page
  14. [19]Ko YJ Lee J-W Yang E-J Jang N Park J Jeon YK. Non-Invasive In Vivo Imaging of Caspase-1 Activation Enables Rapid and Spatiotemporal Detection of Acute and Chronic Inflammatory Disorders. Biomaterials (2020) 226: 119543. doi: 10.1016/j.biomaterials.2019.119543 31634653 · DOI
  15. [20]Munoz-Planillo R Kuffa P Martinez-Colon G Smith BL Rajendiran TM Nunez G. K(+) Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter. Immunity (2013) 38(6): 1142–53. doi: 10.1016/j.immuni.2013.05.016 PMC3730833 23809161 · DOI
  16. [21]Zhou R Yazdi AS Menu P Tschopp J. A Role for Mitochondria in NLRP3 Inflammasome Activation. Nature (2011) 469(7329): 221–5. doi: 10.1038/nature09663 21124315 · DOI · Paper page
  17. [22]Misawa T Takahama M Kozaki T Lee H Zou J Saitoh T. Microtubule-Driven Spatial Arrangement of Mitochondria Promotes Activation of the NLRP3 Inflammasome. Nat Immunol (2013) 14(5): 454–60. doi: 10.1038/ni.2550 23502856 · DOI
  18. [24]Venter G Oerlemans FT Willemse M Wijers M Fransen JA Wieringa B. NAMPT-Mediated Salvage Synthesis of NAD+ Controls Morphofunctional Changes of Macrophages. PloS One (2014) 9(5): e97378. doi: 10.1371/journal.pone.0097378 24824795 PMC4019579 · DOI
  19. [25]Strowig T Henao-Mejia J Elinav E Flavell R. Inflammasomes in Health and Disease. Nature (2012) 481(7381): 278–86. doi: 10.1038/nature10759 22258606 · DOI · Paper page
  20. [26]Shim D-W Lee K-H. Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome. Front Immunol (2018) 9: 1054. doi: 10.3389/fimmu.2018.01054 29868015 PMC5968104 · DOI
  21. [28]He M Chiang H-H Luo H Zheng Z Qiao Q Wang L. An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin Resistance. Cell Metab (2020) 31(3): 580– 91. e5. doi: 10.1016/j.cmet.2020.01.009 32032542 PMC7104778 · DOI · Paper page
  22. [29]Arnoult D Soares F Tattoli I Girardin SE. Mitochondria in Innate Immunity. EMBO Rep (2011) 12(9): 901–10. doi: 10.1038/embor.2011.157 PMC3166463 21799518 · DOI
  23. [30]Agarwal S Ganesh S. Perinuclear Mitochondrial Clustering, Increased ROS Levels, and HIF1 are Required for the Activation of HSF1 by Heat Stress. J Cell Sci (2020) 133(13): jcs245589. doi: 10.1242/jcs.245589 32503939 · DOI
  24. [31]Yu JW Lee MS. Mitochondria and the NLRP3 Inflammasome: Physiological and Pathological Relevance. Arch Pharm Res (2016) 39(11): 1503–18. doi: 10.1007/s12272-016-0827-4 27600432 · DOI
  25. [32]Huang J Xie Y Sun X Zeh HJ 3rd Kang R Lotze MT. Damps, Ageing, and Cancer: The ‘DAMP Hypothesis’. Ageing Res Rev (2015) 24(Pt A): 3– 16. doi: 10.1016/j.arr.2014.10.004 25446804 PMC4416066 · DOI · Paper page
  26. [33]Yegutkin GG. Nucleotide-and Nucleoside-Converting Ectoenzymes: Important Modulators of Purinergic Signalling Cascade. Biochim Biophys Acta (BBA)-Molecular Cell Res (2008) 1783(5): 673–94. doi: 10.1016/j.bbamcr.2008.01.024 18302942 · DOI

Cited by

Sorted by citations

Authors
Shim, D.-W., Cho, H.-J., Hwang, I., Jung, T.-Y., Kim, H.-S., Ryu, J. H., & Yu, J.-W.
Affiliations
  • Yonsei University (KR)
  • Ewha Womans University (KR)
  • Korea Institute of Science and Technology (KR)
Corresponding author
Yu, Je-Wook
Venue
Frontiers in Immunology
Published
2021-12-20
Volume
12
Pages
765477-765477
ISSN
1664-3224 (ISSN-L)
OpenAlex
W4200528937
Cited by
24
References
7
Citations by year
2026: 6 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 1
FWCI
0.86
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
Funders
National Research Foundation of Korea (2020R1A2B5B02001823, 2020R1A4A1019009, 2019R1I1A1A01060316, 2021R1I1A1A01055624)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Keywords
NAD+ depletion, NLRP3 inflammasome, caspase-1 activation, FK866, NAD+ salvage pathway, macrophages, IL-1β, aging, ATP, nigericin, innate immunity, inflammasome priming
MeSH terms
NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Cells, Cultured, Macrophages, Mice, Inbred C57BL, Mice, Transgenic, NAD, Mice, Knockout, Mice, Inflammasomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review